Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00129168
Status:
COMPLETED
Last Update Posted:
2008-04-01
First Post:
2005-08-09
Brief Title:
Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia AML
Sponsor:
Kanisa Pharmaceuticals
Organization:
Kanisa Pharmaceuticals
Organization Data
Organization:
Kanisa Pharmaceuticals
Class:
INDUSTRY
Study ID:
KAN-979-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Kanisa Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None